The Proto-Oncogene Mer Tyrosine Kinase Is a Novel Therapeutic Target in Mantle Cell Lymphoma

Journal of Hematology and Oncology- United Kingdom

doi 10.1186/s13045-018-0584-6

Full Text

Abstract

Available in

Date

Authors

Publisher

Springer Science and Business Media LLC

Related search

C-Mer Proto-Oncogene Tyrosine Kinase (MERTK)

Science-Business eXchange
2013Norwegian

P3.13-04 Lorlatinib in Anaplastic Lymphoma Kinase and Proto-Oncogene Tyrosine-Protein Kinase ROS-Positive Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Polo-Like Kinase 1: A Novel Target for the Treatment of Therapy-Resistant Mantle Cell Lymphoma

Lymphoma
2013English

Phosphatidylinositol 3-Kinase-Δ (PI3K-δ) Is a Potential Therapeutic Target in Adult T-Cell Leukemia-Lymphoma

Biomarker Research
BiochemistryMolecular MedicineClinical Biochemistry
2018English

DNA Sequence, Structure, and Tyrosine Kinase Activity of the Drosophila Melanogaster Abelson Proto-Oncogene Homolog.

Molecular and Cellular Biology
Cell BiologyMolecular Biology
1988English

ISY9-2New Therapeutic Strategies for Mantle Cell Lymphoma

Annals of Oncology
MedicineOncologyHematology
2018English

Mitotic Kinase PBK/TOPK as a Therapeutic Target for Adult T‑cell Leukemia/Lymphoma

International Journal of Oncology
Cancer ResearchOncology
2018English

New and Emerging Bruton Tyrosine Kinase Inhibitors for Treating Mantle Cell Lymphoma – Where Do They Fit In?

Expert Review of Hematology
Hematology
2018English

The CBL Proto-Oncogene Product Negatively Regulates the SRC-Family Tyrosine Kinase Fyn by Enhancing Its Degradation

Molecular and Cellular Biology
Cell BiologyMolecular Biology
2000English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy